logo

For the Inventor, By the Inventor

Nagoya, Japan

Toshiyuki Kouzaki

This inventor holds 5 USPTO granted patents. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1994-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiyuki Kouzaki. Retrieved from https://idiyas.com/inventor/toshiyuki-kouzaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 80.0

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • Aichi, JP (1994)
  • Aichi-ken, JP (1998)
  • Nagoya, JP (1994 - 2007)

Company Filing History:

goldMedal5 out of 108 
 
Sanwa Kagaku Kenkyusho Co., Ltd.
 patents

Years Active: 1994-2007

Loading Chart...
5 patents (USPTO):Explore Patents
1. 7291594 - GLP-1 derivative and preparation thereof absorbable via mucous membrane (2007-11-06),
2. 6703013 - Polystyrene sulfonate-containing gel preparation (2004-03-09),
3. 5733877 - Pharmaceutical composition containing biologically active peptide or (1998-03-31),
4. 5308836 - Pharmaceutical composition of stabilized [Leu.sup.13 ]-motilin-Hse (1994-05-03),
5. 5279835 - Binder-free orally administrable tablet containing 3-oxygermylpropionic (1994-01-18),

Title: Innovations by Toshiyuki Kouzaki

Introduction

Toshiyuki Kouzaki is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of medical technology, particularly in the development of innovative therapeutic solutions. With a total of 5 patents to his name, Kouzaki's work focuses on enhancing drug delivery systems and improving patient care.

Latest Patents

Kouzaki's latest patents include a GLP-1 derivative and preparation thereof absorbable via mucous membrane. This invention provides a GLP-1 derivative that includes an amino acid sequence of GLP-1 (7-35) with specific modifications to enhance its absorption through mucous membranes. Additionally, he has developed a polystyrene sulfonate-containing gel preparation for the therapy of hyperpotassemia. This gel is designed to improve patient comfort and quality of life by minimizing the need for water intake during ingestion.

Career Highlights

Kouzaki is currently associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing therapeutic options for patients with specific medical needs.

Collaborations

Kouzaki collaborates with notable colleagues such as Makoto Sato and Kiichi Sawai, contributing to a dynamic research environment that fosters innovation and development.

Conclusion

Toshiyuki Kouzaki's contributions to medical technology through his patents reflect his commitment to improving healthcare solutions. His innovative approaches are paving the way for enhanced therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…